Uni-Bio Science Group Ltd Sustainability Reports
Uni-Bio Science Group Limited is a biopharmaceutical company focused on the research, development, manufacture, and sale of biological and chemical pharmaceutical products to treat human diseases such as diabetes, osteoporosis, and ophthalmological conditions.
Sector: Manufacturing
Country: Hong Kong
Exchange: Hong Kong Stock Exchange
FIGI: BBG001SFGGG3
21 reports from 2007 to 2025
- Uni-Bio Science Group Ltd 2025 Environmental, Social and Governance Report
- Uni-Bio Science Group Ltd 2024 Annual Report
- Uni-Bio Science Group Ltd 2024 Environmental, Social and Governance Report
- Uni-Bio Science Group Ltd 2023 Environmental, Social and Governance Report
- Uni-Bio Science Group Ltd 2023 Annual Report